Clinical Guidelines of the Russian Society for the Study of the Liver, Russian Gastroenterological Association, Russian Society for the Prevention of Non-Communicable Diseases, Russian Association of Endocrinologists, Russian Scientific Medical Society of Therapists, National Society of Preventive Cardiology, Russian Association of Gerontologists and Geriatricians on Non-Alcoholic Fatty Liver Disease
В. Т. Ивашкин, О. М. Драпкина, М. V. Maevskaya, K. L. Raikhelson, S. V. Okovityi, М. С. Жаркова, V. R. Grechishnikova, Д. И. Абдулганиева, С. А. Алексеенко, M.D. Ardatskaya, И. Г. Бакулин, Н. В. Бакулина, Pavel Bogomolov, В. В. Бредер, E. V. Vinnitskaya, Natalia Geyvandova, Е. В. Голованова, В. Б. Гриневич, В. Л. Дощицин, Е. N. Dudinskaya, Е. В. Ершова, Kh. B. Kodzoeva, И. В. Козлова, K. A. Komshilova, Yu. V. Konev, N. V. Korochanskaya, Yu. V. Kotovskaya, Yu. A. Kravchuk, I.D. Loranskaya, И. В. Маев, A. I. Martynov, С. Н. Мехтиев, Ekaterina Е. Mishina, M. Yu. Nadinskaia, И. Г. Никитин, М. Ф. Осипенко, О. Д. Остроумова, Chavdar S Pavlov, Nana Pogosova, В Г Радченко, Г. Е. Ройтберг, Р. Г. Сайфутдинов, А А Самсонов, P. Seliverstov, С. И. Ситкин, Л. В. Тарасова, А. И. Тарзиманова, О. Н. Ткачева, Evgeny I. Tkachenko, Е. А. Трошина, С. В. Туркина, Yury P. Uspenskiy, Yu. A. Fominykh, О. В. Хлынова, Yu. V. Tsyganova, Минара Шамхаловна Шамхалова, О. О. Шархун, М. В. Шестакова
Abstract
Aim . The clinical guidelines are intended to provide information support for making decisions by gastroenterologists, general practitioners and internists that will improve the quality of medical care for patients with non-alcoholic fatty liver disease, taking into account the latest clinical data and principles of evidence-based medicine. Key points . Clinical guidelines contain information about current views on etiology, risk factors and pathogenesis of nonalcoholic fatty liver disease, peculiarities of its clinical course. Also given recommendations provide information on current methods of laboratory and instrumental diagnostics, invasive and non-invasive tools for nonalcoholic fatty liver disease and its clinical phenotypes assessment, approaches to its treatment, considering the presence of comorbidities, features of dispensary monitoring and prophylaxis. The information is illustrated with algorithms of differential diagnosis and physician's actions. In addition, there is information for the patient and criteria for assessing the quality of medical care. Conclusion . Awareness of specialists in the issues of diagnosis, treatment and follow-up of patients with nonalcoholic fatty liver disease contributes to the timely diagnosis and initiation of treatment, which in the long term will significantly affect their prognosis and quality of life.